This ELISA kit provides quantitative measurement of human interferon-beta (IFNB1) in biological samples, supporting research into type I interferon-mediated innate and adaptive immune responses. Because IFNB1 is rapidly secreted at low concentrations following viral sensing or autoimmune flare and varies dramatically across sample matrices, selecting an assay calibrated to its expected biological range is critical.
Detection Range: The 31.25–2000 pg/mL range spans from baseline circulating IFNB1 levels through the elevated concentrations observed during acute viral infection or in stimulated PBMC supernatants, minimizing the need for extensive sample dilution or concentration steps in most experimental contexts.
Sensitivity: At 15.6 pg/mL, this kit detects IFNB1 in unstimulated or early-timepoint samples where interferon production is just initiating — critical for capturing the kinetics of innate antiviral signaling before peak secretion occurs.
Sample Compatibility: Validation across serum, plasma, cell culture supernatants, saliva, and tissue homogenates enables researchers to correlate systemic IFNB1 levels with local tissue production or in vitro stimulation data within a single study, bridging clinical and mechanistic experiments.
Assay Efficiency: Requiring only 50–100 µL and 1–5 hours, the protocol accommodates limited-volume samples from primary plasmacytoid dendritic cell cultures or longitudinal patient collections without exhausting precious biobank material.
This kit is well-suited for studies in multiple sclerosis therapeutic monitoring, COVID-19 innate immune profiling, and interferonopathy characterization.